Cadre Holdings, Inc. Operating Cash Flow
Cadre Holdings, Inc. (CDRE) reported Operating Cash Flow of $44.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $22.13M, a 755.14% increase year-over-year.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $22.52M, a 29.50% increase year-over-year.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $21.25M, a 10.38% decline year-over-year.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $22.48M.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $63.70M, a 100.48% increase from fiscal 2024.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $31.78M, a 56.59% decline from fiscal 2023.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $73.21M, a 57.75% increase from fiscal 2022.
- Cadre Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $46.41M, a 15.75% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $44.65M 10-Q · filed 2026-08-05 | $65.90M derived: sum of 3 quarters · filed 2026-08-05 | $88.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $22.52M 10-Q · filed 2026-05-11 | $43.77M derived: sum of 2 quarters · filed 2026-05-11 | $66.25M derived: sum of 3 quarters · filed 2026-05-11 | $68.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $21.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $43.73M derived: sum of 2 quarters · filed 2026-03-10 | $46.31M derived: sum of 3 quarters · filed 2026-08-05 | $63.70M 10-K · filed 2026-03-10 |
| 2025-09-30 | $22.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $25.06M derived: sum of 2 quarters · filed 2026-08-05 | $42.45M 10-Q · filed 2025-11-04 | $66.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $19.98M 10-Q · filed 2026-08-05 | $43.69M derived: sum of 3 quarters · filed 2026-08-05 | $38.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $17.39M 10-Q · filed 2026-05-11 | $41.10M derived: sum of 2 quarters · filed 2026-05-11 | $35.89M derived: sum of 3 quarters · filed 2026-05-11 | $47.03M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $23.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $18.50M derived: sum of 2 quarters · filed 2026-03-10 | $29.64M derived: sum of 3 quarters · filed 2026-03-10 | $31.78M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$5.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.93M derived: sum of 2 quarters · filed 2025-11-04 | $8.07M 10-Q · filed 2025-11-04 | $35.02M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $13.28M 10-Q · filed 2025-08-05 | $40.23M derived: sum of 3 quarters · filed 2026-03-10 | $58.22M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $2.14M 10-Q · filed 2025-05-06 | $29.09M derived: sum of 2 quarters · filed 2026-03-10 | $47.08M derived: sum of 3 quarters · filed 2026-03-10 | $62.62M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $26.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $44.94M derived: sum of 2 quarters · filed 2026-03-10 | $60.49M derived: sum of 3 quarters · filed 2026-03-10 | $73.21M 10-K · filed 2026-03-10 |
| 2023-09-30 | $17.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $33.54M derived: sum of 2 quarters · filed 2024-11-06 | $46.26M 10-Q · filed 2024-11-06 | $63.17M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $15.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $28.27M 10-Q · filed 2024-08-09 | $45.18M derived: sum of 3 quarters · filed 2025-03-11 | $49.66M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $12.72M 10-Q · filed 2024-05-08 | $29.63M derived: sum of 2 quarters · filed 2025-03-11 | $34.11M derived: sum of 3 quarters · filed 2025-03-11 | $50.22M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $16.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $21.39M derived: sum of 2 quarters · filed 2025-03-11 | $37.49M derived: sum of 3 quarters · filed 2025-03-11 | $46.41M 10-K · filed 2025-03-11 |
| 2022-09-30 | $4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $20.59M derived: sum of 2 quarters · filed 2023-11-08 | $29.50M 10-Q · filed 2023-11-08 | $38.61M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $16.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $25.02M 10-Q · filed 2023-08-08 | $34.12M derived: sum of 3 quarters · filed 2024-03-12 | $36.41M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | $8.92M 10-Q · filed 2023-05-09 | $18.02M derived: sum of 2 quarters · filed 2024-03-12 | $20.30M derived: sum of 3 quarters · filed 2024-03-12 | $32.18M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $11.39M derived: sum of 2 quarters · filed 2024-03-12 | $23.26M derived: sum of 3 quarters · filed 2024-03-12 | $40.09M 10-K · filed 2024-03-12 |
| 2021-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $14.16M derived: sum of 2 quarters · filed 2022-11-10 | $30.99M 10-Q · filed 2022-11-10 | $48.22M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $11.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $28.71M 10-Q · filed 2022-08-11 | $45.93M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $16.83M 10-Q · filed 2022-05-16 | $34.06M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $17.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $45.42M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $28.19M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |